News | March 15, 2021
Johnson & Johnson single-shot COVID-19 vaccine granted emergency use listing by WHO
The vaccine was 85 percent effective in preventing severe disease across all regions.
The vaccine was 85 percent effective in preventing severe disease across all regions.
With cost optimization leading to cumulative savings of US $80 million over last 8 years, the company now aims to tap bigger opportunities in generics business
Subscribe To Our Newsletter & Stay Updated
